NasdaqCM - Delayed Quote USD
Kezar Life Sciences, Inc. (KZR)
At close: November 6 at 4:00 PM EST
After hours: November 6 at 4:00 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| FOWLER JOHN FRANKLIN Chief Executive Officer | Conversion of Exercise of derivative security | Nov 10, 2022 | 436,115 |
| KIRK CHRISTOPHER J Director | Conversion of Exercise of derivative security | Jul 20, 2023 | 431,348 |
| MORNINGSIDE VENTURE INVESTMENTS, LTD. Beneficial Owner of more than 10% of a Class of Security | Sale | Feb 6, 2023 | 5,447,990 |
| SCHILLER MARK C Officer | Sale | Jul 2, 2024 | 33,007 |
Related Tickers
SPRO Spero Therapeutics, Inc.
1.3100
0.00%
EPIX ESSA Pharma Inc.
1.7100
+0.59%
ATRA Atara Biotherapeutics, Inc.
10.01
-2.68%
ACHL Achilles Therapeutics plc
1.0450
+0.97%
OKUR OnKure Therapeutics, Inc.
16.99
-3.52%
NRBO NeuroBo Pharmaceuticals, Inc.
2.7400
+7.87%
SEER Seer, Inc.
2.0700
+1.97%
UNCY Unicycive Therapeutics, Inc.
0.5020
+1.46%
ZNTL Zentalis Pharmaceuticals, Inc.
3.8400
+1.59%
CTMX CytomX Therapeutics, Inc.
1.0000
+0.70%